A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial. Arch Ital Urol Androl [Internet]. 2026 Nov. 9 [cited 2026 Nov. 11]; Available from: https://www.pagepressjournals.org/aiua/article/view/14712